Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation-Reference-Cited by-同舟云学术

Dosimetric parameters as predictive factors for biochemical control in patients with higher risk prostate cancer treated with Pd-103 and supplemental beam radiation

Published:2007-02 Issue:2 Volume:67 Page:342-346
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Orio Peter,Wallner Kent,Merrick Gregory,Herstein Andrew,Mitsuyama Paul,Thornton Ken,Butler Wayne,Sutlief Steven

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference15 articles.

1. A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy;Potters;Int J Radiat Oncol Biol Phys,2001

2. I-125 versus Pd-103 for low risk prostate cancer: Preliminary biochemical outcomes from a prospective randomized multicenter trial;Wallner;Int J Radiat Oncol Biol Phys,2003

3. Treatment margins predict biochemical outcomes after prostate brachytherapy;Choi;Cancer J (Scientific Am),2004

4. Dosimetric quantifiers for low-dose-rate prostate brachytherapy: Is V100 superior to D90?;Papagikos;Brachytherapy,2005

5. Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results;Stock;Int J Radiat Oncol Biol Phys,2006

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Permanent prostate brachytherapy postimplant magnetic resonance imaging dosimetry using positive contrast magnetic resonance imaging markers;Brachytherapy;2017-07

2. Cone-beam CT-based adaptive planning improves permanent prostate brachytherapy dosimetry: An analysis of 1266 patients;Medical Physics;2017-03-22

3. Prostate deformation from inflatable rectal probe cover and dosimetric effects in prostate seed implant brachytherapy;Medical Physics;2016-11-17

4. Is it necessary to perform week three dosimetric analysis in low-dose-rate brachytherapy for prostate cancer when day 0 dosimetry is done? A quality assurance assessment;Brachytherapy;2015-05

5. Large prostate gland size is not a contraindication to low-dose-rate brachytherapy for prostate adenocarcinoma;Brachytherapy;2014-09